<p> EASD Diabetes & Cardiovascular Disease Study Group THE SECOND ANNUAL MEETING 5-7 November 2009 Cluj-Napoca, Romania City Plaza Conference Center</p><p>Chairpersons Antonio Ceriello, UK Nicolae Hancu, Romania</p><p>Scientific Committee</p><p>Antonio Ceriello, Carlo B. Giorda N. Hancu, J. Petrie, E. Standl, J. Tuomilehto, P. Valensi</p><p>ADVANCED PRELIMINARY PROGRAMME Day 1 Thursday, November 5, 2009 Time Title Presenter 13.00-14.00 LUNCH 14.00-14.30 Welcome N.Hancu Introduction to D&CVD Annual Meeting A. Ceriello Session 1: New Scenarios 14.30-14.50 How can we evaluate what we do? G. Vespasiani, Italy The “Annali AMD” Experience 14.50-15.10 Sleep Disorders and Diabetes Franco Cappuccio, UK 15.10-15.30 Glucose management in the hospital D. Tschoepe, Germany 15.30-15.50 Benefit-Risk evaluation of strict glycaemic G. Schernthaner, Austria control for the prognosis of Patients with type 2 diabetes 15.50-16.20 BREAK 16.20-16.50 Q&A guided session 16.50-18.10 Session 2: Oral presentations 18.05-18.20 Summary 18.30 WELCOME RECEPTION Day 2 Friday, November 6, 2009</p><p>Time Title Presenter Session 3: Emerging co-morbidities (1) 8.20-8.30 Welcome 8.30-8.50 Heart Failure and diabetes Helene von Bibra, Germany 8.50-9.20 Acute heart failure in diabetes G.E. Ambrosio, Italy 9.20-9.40 Silent CHD P.Valensi, France 9.40-10.00 BREAK 10.00-10.30 Q&A guided session 10.30-11.15 Session 4: Oral presentations Session 5: Emerging co-morbidities (2) 11.15-11.35 Acute coronary syndromes and diabetes S. Eckert, Germany 11.35-11.55 Cardiovascular Prevention in Type 2 Diabetes- Avner Lifshitz, Israel a primary care perspective 11.55-12.15 Drug Discovery & Translational Medicine I.M. Shah, UK research in the treatment of Diabetic nephropathy 12.15-12.45 Q&A guided session 12.45-13.15 General Assembly 13.15-14.45 LUNCH 13.45-14.45 POSTER PRESENTATION Session 6: New insights in vascular damage Chair 14.45-15.05 Using arterial stiffness indices as targets for JK Cruickshank, UK treatment 15.05-15.25 Postprandial endothelial dysfunction- A. Stirban, Germany therapeutic options 15.25-15.45 Q&A guided session 15.45-16.45 Session 7: Oral presentations 16.45-16.20 BREAK 16.20-18.20 Session 8: Oral presentations 18.20-19.00 Summary of the day 19.30 DINNER Day 3 Saturday, November 7, 2009</p><p>Time Title Presenter Session 9: Diabetes and CVD: an update in basic science 8.20-8.30 Welcome 8.30-8.50 Pharmacogenetics in diabetes E.R. Pearson, UK 8.50-9.10 Glycation of LDL and HDL and risk of Naila Rabbani, UK cardiovascular disease in diabetes 9.10-9.30 Translation of experimental AGE research to PJ. Thornalley, UK clinical diagnostics and therapeutics 9.30-9.45 BREAK 9.45-10.15 Q&A guided session 10.15- 11.45 Session 10: Oral presentations 11.45-13.00 Summary of the day Closing ceremony 13.00 LUNCH</p>